OWP Pharmaceuticals Announces Commercial Product Availability of SUBVENITE® (lamotrigine) Oral Suspension in U.S. Market

LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
Reuters

Lupin gets USFDA nod for lamotrigine tablets

MUMBAI, June 4 (Reuters) - Lupin Ltd said on Friday its unit has received U.S. FDA approval for lamotrigine in tablets form. Lamotrigine tablets, used in the treatment of bipolar-I disorder, are a ...
Business Wire

Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Lamotrigine ODT, USP ...